|
|
Position:
Senior Scientist, DMPK/Clinical Pharmacology
Employer:
Agios Pharmaceuticals
Description:
Agios Pharmaceuticals is searching for a dynamic Senior Scientist to join our growing DMPK/Clinical Pharmacology team. The Senior Scientist will be responsible for working with various CROs for designing and analyzing in-vitro/in-vivo ADME studies and addressing issues related to metabolism and drug-drug interactions for both discovery and development programs. The ideal candidate will have a proven ability in identification of biotransformation pathways and metabolic enzymes/drug transporters involved in disposition of new therapeutic agents. A successful candidate should be able to exhibit strong communication and interpersonal skills and desire to work in a fast-paced, flexible and dynamic environment.
Key Responsibilities
- Design and execute in vitro and in vivo (preclinical and clinical) drug metabolism/ADME studies in support of discovery and development programs
- Metabolic soft-spot identification and assessment reactive pathways to guide medicinal chemistry efforts in lead discovery and optimization
- Elucidate biotransformation pathways and determine the role of metabolic enzymes (CYP & non-CYPs) and drug transporters involved in the disposition of new chemical entities
- Identification of drug interaction liabilities due to enzyme/transporter substrate/inhibition/induction and set-up exclusion criteria in first-in-human trials
- Provides leadership in clinical DDI study design based on clearance pathways, phenotyping and alteration of metabolic enzymes/drug-transporters activity
- Serve as a subject matter expert in drug metabolism and DDIs with in DMPK/Clinical Pharmacology
- Contribute for drafting INDs, IBs, briefing books and NDA documents to support regulatory submissions
Qualifications/Experience:
Minimum Requirements
- Applicants should possess a PhD or Masters in Organic Chemistry/Medicinal Chemistry /Pharmaceutical Sciences with 5+ (PhD) or 8+ years (Masters) of pharmaceutical industry experience
- Good understanding of organic chemistry principles/structural elucidation of small molecules and xenobiotic metabolism is required
- The candidate should have extensive experience interpreting mass spectral (LC-MS) data and other structural elucidation techniques such as NMR, chemical derivatization etc.
- Strong knowledge in clinical relevance of clearance mechanisms and role of enzymes (CYPs & non-CYPs) and transporters in drug metabolism is required
- Thorough understanding of metabolism and DDI regulatory guidelines is an asset
- Ability to work independently with a minimum supervision, design experiments and report data in written reports and team presentations as required
- The individual is also expected to be highly organized, a team player, enthusiastic about drug discovery, and possess strong communication and collaborative skills
Preferred Qualifications
- Experience in conducting radio-labeled ADME studies is preferred
- Hands-on experience in translational PBPK modeling to predict pharmacokinetic based drug interactions is highly desirable
- Publications in peer-reviewed scientific journals is desirable
Location:
Cambridge, MA
Contact:
jayaprakasam.bolleddula@agios.com
Post Date:
1/22/2020 12:00:00 AM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Submit a Text Ad
|